Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 6
2004 1
2005 3
2006 3
2007 4
2008 2
2009 5
2010 5
2011 10
2012 3
2013 8
2014 6
2015 9
2016 6
2017 4
2018 7
2019 6
2020 4
2021 11
2022 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

96 results

Results by year

Filters applied: . Clear all
Page 1
The pro-tumoral function of HACE1.
El-Hachem N, Ballotti R. El-Hachem N, et al. Among authors: ballotti r. Oncoscience. 2018 Jun 23;5(5-6):128-129. doi: 10.18632/oncoscience.418. eCollection 2018 May. Oncoscience. 2018. PMID: 30035162 Free PMC article. No abstract available.
Single-cell RNA sequencing reveals intratumoral heterogeneity in primary uveal melanomas and identifies HES6 as a driver of the metastatic disease.
Pandiani C, Strub T, Nottet N, Cheli Y, Gambi G, Bille K, Husser C, Dalmasso M, Béranger G, Lassalle S, Magnone V, Pédeutour F, Irondelle M, Maschi C, Nahon-Estève S, Martel A, Caujolle JP, Hofman P, LeBrigand K, Davidson I, Baillif S, Barbry P, Ballotti R, Bertolotto C. Pandiani C, et al. Among authors: ballotti r. Cell Death Differ. 2021 Jun;28(6):1990-2000. doi: 10.1038/s41418-020-00730-7. Epub 2021 Jan 18. Cell Death Differ. 2021. PMID: 33462406 Free PMC article.
LKB1-SIK2 loss drives uveal melanoma proliferation and hypersensitivity to SLC8A1 and ROS inhibition.
Proteau S, Krossa I, Husser C, Guéguinou M, Sella F, Bille K, Irondelle M, Dalmasso M, Barouillet T, Cheli Y, Pisibon C, Arrighi N, Nahon-Estève S, Martel A, Gastaud L, Lassalle S, Mignen O, Brest P, Mazure NM, Bost F, Baillif S, Landreville S, Turcotte S, Hasson D, Carcamo S, Vandier C, Bernstein E, Yvan-Charvet L, Levesque MP, Ballotti R, Bertolotto C, Strub T. Proteau S, et al. Among authors: ballotti r. EMBO Mol Med. 2023 Dec 7;15(12):e17719. doi: 10.15252/emmm.202317719. Epub 2023 Nov 15. EMBO Mol Med. 2023. PMID: 37966164 Free PMC article.
Focus on cutaneous and uveal melanoma specificities.
Pandiani C, Béranger GE, Leclerc J, Ballotti R, Bertolotto C. Pandiani C, et al. Among authors: ballotti r. Genes Dev. 2017 Apr 15;31(8):724-743. doi: 10.1101/gad.296962.117. Genes Dev. 2017. PMID: 28512236 Free PMC article. Review.
Recent advances in understanding the role of HES6 in cancers.
Krossa I, Strub T, Martel A, Nahon-Esteve S, Lassalle S, Hofman P, Baillif S, Ballotti R, Bertolotto C. Krossa I, et al. Among authors: ballotti r. Theranostics. 2022 May 20;12(9):4374-4385. doi: 10.7150/thno.72966. eCollection 2022. Theranostics. 2022. PMID: 35673577 Free PMC article. Review.
Immune Checkpoints in Cancers: From Signaling to the Clinic.
Pisibon C, Ouertani A, Bertolotto C, Ballotti R, Cheli Y. Pisibon C, et al. Among authors: ballotti r. Cancers (Basel). 2021 Sep 12;13(18):4573. doi: 10.3390/cancers13184573. Cancers (Basel). 2021. PMID: 34572799 Free PMC article. Review.
Lysine Methyltransferase NSD1 and Cancers: Any Role in Melanoma?
Krossa I, Strub T, Aplin AE, Ballotti R, Bertolotto C. Krossa I, et al. Among authors: ballotti r. Cancers (Basel). 2022 Oct 5;14(19):4865. doi: 10.3390/cancers14194865. Cancers (Basel). 2022. PMID: 36230787 Free PMC article. Review.
96 results